Intravitreal Anti-VEGF Injection is a specialized eye treatment used to manage retinal diseases caused by abnormal blood vessel growth and leakage in the retina. VEGF (Vascular Endothelial Growth Factor) is a protein that stimulates the formation of these abnormal vessels, leading to swelling, bleeding, and vision loss in conditions like age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion. The injection delivers anti-VEGF medicine directly into the vitreous cavity of the eye, blocking VEGF activity, reducing swelling, and preventing further damage. It is a quick, minimally invasive procedure performed under local anesthesia, with the aim of preserving and improving vision.

• Directly delivers anti-VEGF medicine into the eye.
• Treats retinal diseases like AMD, diabetic retinopathy, and vein occlusion.
• Reduces abnormal blood vessel growth and leakage.
• Helps decrease swelling in the retina.
• Minimally invasive and performed under local anesthesia.
• Aims to preserve and improve vision.